Impulse Dynamics’ CEO Says CMS Breakthrough Rule Could Boost R&D, Good Use Of Tax Dollars

Following CMS’ recent proposed rule to give immediate national coverage for breakthrough medical devices, Impulse Dynamics’ CEO Simos Kedikoglou spoke with Medtech Insight about what it could mean for companies like his.

Om Podcasten

Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.